Literature DB >> 30285057

Association of Initially Normal Coronary Arteries With Normal Findings on Follow-up Echocardiography in Patients With Kawasaki Disease.

Sarah D de Ferranti1,2, Kimberlee Gauvreau1,2, Kevin G Friedman1,2, Alexander Tang1,2,3, Annette L Baker1,2, David R Fulton1,2, Adriana H Tremoulet4,5, Jane C Burns4,5, Jane W Newburger1,2.   

Abstract

Importance: American Heart Association guidelines recommend echocardiography in Kawasaki disease at baseline, 1 to 2 weeks, and 4 to 6 weeks after treatment to detect coronary artery abnormalities. However, these examinations are expensive and may require sedation in young children, which is burdensome and carries some risk. Objective: To assess the benefit of additional echocardiographic imaging at 6 weeks in patients with uncomplicated Kawasaki disease who had previously normal coronary arteries. Design, Setting, and Participants: This is a retrospective review of patients with Kawasaki disease who were cared for between 1995 and 2014 in 2 academic pediatric referral practices Eligibility criteria included receiving intravenous immunoglobulin treatment for acute Kawasaki disease at a center; the absence of significant congenital heart disease; available echocardiographic measurements of both the right and left anterior descending coronary arteries at 10 days or less after diagnosis (baseline), 2 (±1) weeks, and 6 (±3) weeks of illness; and normal coronary arteries at baseline and 2 weeks, defined as maximum coronary artery z scores less than 2.0 and no distal aneurysms. Data analysis was completed from March 2015 to November 2015. Main Outcomes and Measures: The number of patients with right coronary artery or left anterior descending coronary artery z scores of 2.0 or more at 6 weeks.
Results: The median age of the 464 included patients was 3.3 years (interquartile range, 1.8-5.4 years); 264 (56.9%) were male, 351 of 414 for whom data were available (84.8%) had complete Kawasaki disease, and 66 (14.2%) received additional intravenous immunoglobulin treatment. At 6 weeks of illness, 456 patients (98.3%) who had had normal coronary artery z scores at baseline and 2 weeks continued to have normal z scores. Of the remaining 8 patients (1.7%), the maximum z score within 6 weeks was 2.0 to 2.4 in 5 patients (1.2%), 2.5 to 2.9 in 1 patient (0.2%), and 3.0 or more in 2 patients (0.4% [95% CI, 0.1%-1.5%]). Coronary artery dimensions ultimately normalized in all but 1 patient, who had minimal dilation at 6 weeks (right coronary artery z score, 2.1). Sensitivity analyses using less restrictive cut points (eg, a maximum z score <2.5) or less restrictive timing windows (eg, considering patients with incomplete echocardiographic data within 21 days) gave similar results; in these analyses, 454 to 463 of 464 patients (98% to 99.7%) had coronary artery z scores of less than 2.5 at 6 weeks. Conclusions and Relevance: New abnormalities in coronary arteries are rarely detected at 6 weeks in patients with Kawasaki disease who have normal measurements at baseline and 2 weeks of illness, suggesting that the 6-week echocardiographic imaging may be unnecessary in patients with uncomplicated Kawasaki disease and z scores less than 2.0 in the first 2 weeks of illness.

Entities:  

Mesh:

Year:  2018        PMID: 30285057      PMCID: PMC6583021          DOI: 10.1001/jamapediatrics.2018.3310

Source DB:  PubMed          Journal:  JAMA Pediatr        ISSN: 2168-6203            Impact factor:   16.193


  14 in total

1.  Coronary Artery Aneurysm Measurement and Z Score Variability in Kawasaki Disease.

Authors:  Christina Ronai; Akiko Hamaoka-Okamoto; Annette L Baker; Sarah D de Ferranti; Steven D Colan; Jane W Newburger; Kevin G Friedman
Journal:  J Am Soc Echocardiogr       Date:  2015-09-19       Impact factor: 5.251

Review 2.  Kawasaki Disease.

Authors:  Jane W Newburger; Masato Takahashi; Jane C Burns
Journal:  J Am Coll Cardiol       Date:  2016-04-12       Impact factor: 24.094

3.  Coronary artery dimensions may be misclassified as normal in Kawasaki disease.

Authors:  A de Zorzi; S D Colan; K Gauvreau; A L Baker; R P Sundel; J W Newburger
Journal:  J Pediatr       Date:  1998-08       Impact factor: 4.406

4.  Prevalence of Undiagnosed Structural Heart Disease in Children Undergoing Echocardiography for Kawasaki Disease.

Authors:  Christina Ronai; Annette L Baker; Kevin G Friedman; David R Fulton; Jane W Newburger; Peter Lang
Journal:  Clin Pediatr (Phila)       Date:  2015-07-07       Impact factor: 1.168

5.  Cost-effective use of echocardiography in children with Kawasaki disease.

Authors:  J S Scott; J A Ettedgui; W H Neches
Journal:  Pediatrics       Date:  1999-11       Impact factor: 7.124

6.  A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan.

Authors:  T Kawasaki; F Kosaki; S Okawa; I Shigematsu; H Yanagawa
Journal:  Pediatrics       Date:  1974-09       Impact factor: 7.124

Review 7.  Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association.

Authors:  Brian W McCrindle; Anne H Rowley; Jane W Newburger; Jane C Burns; Anne F Bolger; Michael Gewitz; Annette L Baker; Mary Anne Jackson; Masato Takahashi; Pinak B Shah; Tohru Kobayashi; Mei-Hwan Wu; Tsutomu T Saji; Elfriede Pahl
Journal:  Circulation       Date:  2017-03-29       Impact factor: 29.690

8.  Prevalence of coronary artery abnormalities in Kawasaki disease is highly dependent on gamma globulin dose but independent of salicylate dose.

Authors:  M Terai; S T Shulman
Journal:  J Pediatr       Date:  1997-12       Impact factor: 4.406

9.  Coronary artery involvement in children with Kawasaki disease: risk factors from analysis of serial normalized measurements.

Authors:  Brian W McCrindle; Jennifer S Li; L LuAnn Minich; Steven D Colan; Andrew M Atz; Masato Takahashi; Victoria L Vetter; Welton M Gersony; Paul D Mitchell; Jane W Newburger
Journal:  Circulation       Date:  2007-06-18       Impact factor: 29.690

10.  Hospitalizations for Kawasaki syndrome among children in the United States, 1997-2007.

Authors:  Robert C Holman; Ermias D Belay; Krista Y Christensen; Arianne M Folkema; Claudia A Steiner; Lawrence B Schonberger
Journal:  Pediatr Infect Dis J       Date:  2010-06       Impact factor: 2.129

View more
  5 in total

1.  Prognosis and Risk Factors of Coronary Artery Lesions before Immunoglobulin Therapy in Children with Kawasaki Disease

Authors:  Huixian Qiu; Chang Jia; Zhenquan Wang; Yuee He; Xing Rong; Rongzhou Wu; Maoping Chu; Hongying Shi
Journal:  Balkan Med J       Date:  2020-07-28       Impact factor: 2.021

Review 2.  Berberine: A Review of its Pharmacokinetics Properties and Therapeutic Potentials in Diverse Vascular Diseases.

Authors:  Xiaopeng Ai; Peiling Yu; Lixia Peng; Liuling Luo; Jia Liu; Shengqian Li; Xianrong Lai; Fei Luan; Xianli Meng
Journal:  Front Pharmacol       Date:  2021-11-03       Impact factor: 5.810

3.  The Negative Predictive Value of Harada Scoring for Coronary Artery Dilatation or Aneurysm in Children with Kawasaki Disease: A Cross-sectional Study.

Authors:  Abdolreza Malek; Alireza Ghodsi; Abdolkarim Hamedi
Journal:  Iran J Med Sci       Date:  2022-07

4.  Neutrophil-to-lymphocyte ratio and scoring system for predicting coronary artery lesions of Kawasaki disease.

Authors:  Ling-Sai Chang; Yi-Ju Lin; Jia-Huei Yan; Mindy Ming-Huey Guo; Mao-Hung Lo; Ho-Chang Kuo
Journal:  BMC Pediatr       Date:  2020-08-24       Impact factor: 2.125

5.  Neutrophil extracellular trap from Kawasaki disease alter the biologic responses of PBMC.

Authors:  Yang Jing; Meng Ding; Jiuyuan Fu; Yanping Xiao; Xianghua Chen; Qingyun Zhang
Journal:  Biosci Rep       Date:  2020-09-30       Impact factor: 3.840

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.